Comparison of clinical significance of novel reactive oxygen species biomarker among new categories of non-ischemic heart failure

Comparison of clinical significance of novel reactive oxygen species biomarker among new categories of non-ischemic heart failure - Reactive oxygen species in non-ischemic heart failure

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035827

Enrollment

300

Registered

2019-02-14

Start date

2007-02-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-ischemic heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with heart failure who were hospitalized in Kumamoto University Hospital

Exclusion criteria

Exclusion criteria: Do not meet diagnostic criteria for non-ischemic heart failure Severe valvular disease Active infection diseases History of malignancy End stage of chronic kidney diseases

Design outcomes

Primary

Measure	Time frame
Composite endpoint of cardiovascular death, non-fatal myocardial infarction, unstable angina pectoris, non-fatal stroke, or re-hospitalization for heart failure	—

Countries

Japan

Contacts

Public ContactTaiki Nishihara

Graduate School of Medical Sciences, Kumamoto University Department of Cardiovascular Medicine

t-nishi@kumamoto-u.ac.jp81-96-373-5175

Outcome results